Search Results

China's First Homegrown Radiopharmaceutical Receives Dual FDA Breakthrough Therapy and Fast Track Designations

On August 6, Nuoyu Medical announced that the U.S. Food and Drug Administration (FDA) has officially granted Breakthrough Therapy Designation (BTD) and Fast Track Designation (FTD) to the company's independently developed 68Ga-NYM096. This marks the first product in China's original radiopharmaceutical field to receive FDA Breakthrough Therapy Designation, and the first to receive both FDA Breakthrough Therapy and Fast Track designations simultaneously, creating a milestone breakthrough in the radiopharmaceutical field. 68Ga-NYM096 is a small-molecule diagnostic radiopharmaceutical for renal cancer that specifically binds to CAIX, suitable for positron emission tomography (PET) imaging of suspected or confirmed metastatic clear cell renal cell carcinoma (c...

2026-08-08

StarRing Fusion Completes RMB 880 Million Series A++ Financing to Advance Fusion Device and Key Technology Engineering

StarRing Fusion recently announced the completion of a new Series A++ financing round, raising RMB 880 million. This round was jointly invested by Shenzhen Capital Group, Shendan Venture Capital, ABC Capital, BOCOM Investment, GGV Capital, Yongxin Ark, Keke Capital, Advantage Capital, and other institutions, with existing shareholder Shanghai Science and Technology Innovation Group's intellectual property fund and other institutions continuing to follow on. The company stated that the proceeds from this round, together with the previous Series A and A+ financing, will be used for the construction of the Shanghai Jiading experimental base, the construction and operation of the NTST negative-triangularity spherical tokamak, the design and construction of the CTRFR-1 "StarRing One," and the continued engineering advancement of key technologies including fusion-grade high-temperature superconducting magnets and AI-based plasma control...

2026-08-08

CNNC Fuzhi Officially Established, CNNC Isotope Holds 90% Stake to Integrate the Full Nuclear Medicine Industry Chain

On August 6, 2026, CNNC Fuzhi (Beijing) Technology Co., Ltd. (hereinafter referred to as "CNNC Fuzhi") was officially established. The company was jointly funded by CNNC Isotope Co., Ltd. (hereinafter referred to as "CNNC Isotope") and CNNC (Zhejiang) Innovation Co., Ltd. (hereinafter referred to as "CNNC Zhejiang Innovation"), with CNNC Isotope holding 90% of the shares and CNNC Zhejiang Innovation holding 10%. CNNC Fuzhi will take over the business of CNNC Isotope's Nuclear Medicine Development Center, focusing on deep cultivation in the smart nuclear medicine sector. With the smart nuclear medicine IoT system as its core carrier, the company aims to integrate the entire nuclear medicine industry chain, build a synergistic development model of "smart nuclear medicine system + nuclear drugs + equipment + services," and drive the business transition from single product supply to full value chain integration...

2026-08-08

Liu Mingsheng, Party Secretary and Chairman of SPIC, Conducts Research Visit to SPIC Laiyang

On August 6, Liu Mingsheng, Party Secretary and Chairman of State Power Investment Corporation (SPIC), conducted a research visit to SPIC Laiyang, where he conveyed and studied the spirit of the State Council Executive Meeting held on July 31, inspected the site of the Laiyang Nuclear Power Project, and chaired a research symposium. Liu Mingsheng affirmed the overall work approach of SPIC Laiyang. Liu Mingsheng pointed out that Laiyang Nuclear Power, as the first implementation project for the standardization and batch construction of "Guohe No.1", is of extremely significant importance to the Group's high-quality development of nuclear power. It is essential to conscientiously implement the spirit of the State Council Executive Meeting on July 31, construct and operate nuclear power units in accordance with the world's highest safety standards, always adhere to the principle of "safety first, quality first", prioritize nuclear safety at the highest level, and ensure absolute safety in nuclear operations. It is necessary to unify thinking, strengthen confidence, scientifically grasp opportunities and challenges, continuously enhance the maturity of the "Guohe No.1" reactor design, accelerate the improvement of its competitiveness, strengthen nuclear power construction management capabilities and talent team development, build the Laiyang Nuclear Power Project to high standards and high quality, polish the "Guohe No.1" brand, develop replicable and scalable management models and experience, and promote large-scale development.

2026-08-08

Professor Lin Guoxian from the BC Cancer Agency Delivers Academic Exchange at the Institute of Radiation Medicine, Chinese Academy of Medical Sciences

Lin Guoxian: Professor at the BC Cancer Agency, whose research focuses on the development of targeted radiopharmaceuticals for the diagnosis and treatment of various tumors. To date, he has led/participated in the publication of over 135 peer-reviewed journal articles, filed more than 30 patent applications related to radiopharmaceuticals, and completed the clinical translation of 7 self-developed radiopharmaceuticals for the diagnosis and treatment of multiple tumor types. During the seminar, Professor Lin Guoxian, based on his team's years of frontier exploration, systematically reviewed the research progress of nuclear drugs targeting PSMA for prostate cancer: first, the molecular design and clinical advantages of F-18 labeled PSMA-targeted PET imaging agents; second, the substantial improvement of tumor targeting of Lu-177 labeled therapeutic radiopharmaceuticals through rational optimization of molecular structures,...

2026-08-07

Container Non-Opening Inspection and Screening System Commissioned at Logistics Center in Moscow Oblast, Russia

According to the press service of the Moscow Oblast Ministry of Investment, Industry and Science, the Selyatino Transport and Logistics Center (TLC), located in the Naro-Fominsk urban district of Moscow Oblast, Russia, has installed a modern inspection and screening facility to improve the efficiency of container cargo inspection and the level of transport safety. The equipment enables rapid inspection of cargo inside containers without opening them, helping staff determine whether dangerous goods or related substances are present inside. Yekaterina Zinovieva, Deputy Prime Minister of Moscow Oblast and Minister of Investment, Industry and Science, stated that deploying such systems is one of the measures in the region to enhance the safety of cargo storage and transportation at container yards...

2026-08-07

Institute of Radiation Medicine, Chinese Academy of Medical Sciences Hosts Academic Seminar on PSMA-Targeted Radiopharmaceuticals

On August 3, the Institute of Radiation Medicine, Chinese Academy of Medical Sciences held an academic seminar, inviting Professor Lin Guoxian from the BC Cancer Agency in Vancouver, Canada, to deliver a lecture titled "Development of Prostate-Specific Membrane Antigen-Targeted Radiopharmaceuticals for the Diagnosis and Treatment of Prostate Cancer." The seminar was held in a hybrid format, with some researchers and graduate students from the institute attending in person. Professor Lin Guoxian has long been engaged in the development of targeted radiopharmaceuticals for cancer diagnosis and therapy, having led or contributed to the publication of over 135 peer-reviewed journal articles, filed more than 30 patent applications related to radiopharmaceuticals, and completed clinical translation of 7 self-developed radiopharmaceuticals applied in...

2026-08-07

Hu Jinjun, Member of the Standing Committee of the Guangdong Provincial Party Committee and Head of the Publicity Department, Conducts Research in Huizhou: Advancing Marine Economy Toward High-Quality Development by Leveraging the Sea

Recently, Hu Jinjun, Member of the Standing Committee of the Guangdong Provincial Party Committee and Head of the Publicity Department, conducted research in Huizhou, emphasizing the need to thoroughly study and implement General Secretary Xi Jinping's important expositions on promoting high-quality development of the marine economy, implement the provincial party committee's deployment requirements, orderly advance post-disaster recovery from Severe Typhoon Hongxia, consolidate the foundation during resumption of work and production, adhere to leveraging the sea for strength, and accelerate the high-quality development of the marine economy. Hu Jinjun and his delegation visited Guangdong Huangjing Marine Biotechnology Co., Ltd., Haozhaolou Wetland Park, the two major scientific facilities of the Chinese Academy of Sciences, CGN Taipingling Nuclear Power Station, and Unilumin Technology Huizhou Daya Bay Science and Technology Park, among other sites, to learn about the protection of Chinese bahaba germplasm resources and innovation in the southern sea large yellow croaker seed industry, marine ecological protection, commercialization of achievements from major scientific facilities, construction and operation of major energy projects, and R&D and manufacturing of cultural equipment, expressing recognition for the relevant work.

2026-08-07

DUNE Integrates Artificial Intelligence into Neutrino Experiment to Enhance Particle Detection and Data Processing Capabilities

The team at the U.S. Fermi National Accelerator Laboratory is advancing the Deep Underground Neutrino Experiment (DUNE) by integrating artificial intelligence and machine learning tools into experiment design, detector operations, and data analysis workflows, aiming to improve neutrino interaction identification, event classification, and detector management capabilities. Located at the Long-Baseline Neutrino Facility, DUNE has begun installing structural components for its large neutrino detector modules. The experiment consists of a near detector and a far detector: the near detector is situated at Fermilab, while the far detector is located approximately one mile underground at the Sanford Underground Research Facility in South Dakota. Both detectors will employ liquid argon time projection chamber technology to record neutrino...

2026-08-07

U.S. NRC to Debut Modernized Hearing Process in Advanced Reactor Licensing Review for the First Time

The U.S. Nuclear Regulatory Commission (NRC) will hold a public hearing on August 13 in Oak Ridge, Tennessee, to consider the Tennessee Valley Authority's (TVA) application to build a small modular reactor at the Clinch River site. This will mark the first time the NRC applies its modernized mandatory hearing framework in an advanced reactor licensing review. According to the NRC, the new hearing process is designed to give the public earlier insight into the agency's review of the project's safety and environmental impacts, while improving the transparency, predictability, and efficiency of licensing reviews. As part of its licensing modernization efforts, the NRC currently aims to complete construction permit-related decisions within 18 months. TVA plans to...

2026-08-07

SHINE Selected for Two U.S. Department of Energy AI Nuclear Fuel Recycling Projects

SHINE Technologies, a U.S. fusion energy company, has recently been selected for projects under the U.S. Department of Energy's Genesis Mission, participating in two artificial intelligence applications for the nuclear energy sector. Among these, SHINE will lead a nuclear fuel cycle facility optimization project and join the Prometheus project, a collaborative effort between national laboratories and industry. The project led by SHINE, named AI-Guided Fuel Cycle Facility Optimization, is a Phase 1 project with Argonne National Laboratory as the technical partner. The project plans to develop an AI-assisted workflow to help engineers...

2026-08-07

First Clinical Treatment Successfully Completed with China's Domestic Superconducting Cyclotron Proton Therapy System by CYC-Ion

On the morning of August 7, the domestically developed superconducting cyclotron proton therapy system, independently developed by Hefei CYC-Ion Medical Technology Equipment Co., Ltd., completed the first clinical trial treatment of a subject at Hefei Ion Medical Center. This marks a significant breakthrough as the first domestically produced superconducting cyclotron proton radiation therapy system in China. The subject in this case was a lung cancer patient. The superconducting proton therapy system used in the trial is equipped with the SC240 superconducting cyclotron independently developed by CYC-Ion, featuring an ultra-large irradiation field and 360° full-angle beam delivery capability. The entire treatment process relied on multi-modal fusion 4D image-guided precise positioning, enabling dynamic adaptation and precise treatment. The equipment operated smoothly with low noise, and the treatment control software ran...

2026-08-07

Indonesia's BRIN Showcases Nuclear Technology Research Progress, Covering Radiopharmaceuticals and Food Irradiation Applications

The National Research and Innovation Agency (BRIN) of Indonesia recently showcased its nuclear technology research achievements at the Presidential Palace in Jakarta. BRIN Head Arief Satria stated that the relevant technologies fall within the scope of peaceful uses of nuclear energy, with applications extending beyond energy to also cover food and health sectors. In the health sector, BRIN is developing radiopharmaceuticals for nuclear medicine. These drugs contain radioactive substances and can be used for cancer diagnosis and treatment. Arief stated that radiopharmaceutical research and development is of great significance for cancer detection and therapy. In the food sector, BRIN applies nuclear technology to food preservation, with a focus on irradiation treatment of export fruits. Arief explained that some importing countries re...

2026-08-07

American Fusion Adds Six New Patent Applications for Texatron Fusion Technology

On August 6, American Fusion announced that it has filed six new patent applications in the United States covering multiple technical aspects of its proprietary Texatron Fusion Engine platform. This brings the company's total number of patent applications filed in the U.S. to 82. American Fusion stated that these applications continue its strategy of building an intellectual property portfolio around the Texatron platform, covering reactor architecture, plasma confinement, electromagnetic systems, fuel delivery, reactor control, power management, and related engineering technologies supporting the continued development and future commercialization of the Texatron Fusion Engine. The company's Chief Legal Officer, Michael G....

2026-08-07

First Validation of Novel PRI Technology: Existing PET Tracers Can Image Tissue Microenvironment

August 6, 2026 - A joint research team from the Graduate School of Engineering at the University of Tokyo and the University of York in the UK announced that they have established a novel geometric imaging principle utilizing positron three-photon decay and successfully validated Positronium Ratio Imaging (PRI) technology for the first time. This method can be used in conjunction with existing clinical PET tracers and is expected to provide a new means of observing tissue microenvironments in nuclear medicine imaging. Conceptual diagram of next-generation nuclear medicine imaging utilizing positron-3-photon decay. Current clinical PET scans primarily rely on the positron two-photon annihilation process to visualize the distribution and accumulation of tracers in the body, but they provide limited information on microenvironmental factors such as tissue hypoxia that are associated with disease malignancy...

2026-08-07